Drugs / STIL101
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06626256 | Dec 2025 → Oct 2027 | cervical carcinoma, colorectal carcinoma, metastatic malignant neoplasm, metastatic melanoma +2 | City of Hope Medical Center | Withdrawn | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | STIL101 | “STIL101 for injection, an autologous (made from the patients own cells) cellular therapy, is made up of specialized white blood cells called lymphocytes or "T cells" collected...” NCT06626256 ↗ |
| Known as | STIL101 for injection | “STIL101 for injection, an autologous (made from the patients own cells) cellular therapy, is made up of specialized white blood cells called lymphocytes or "T cells" collected...” NCT06626256 ↗ |
| Modality | Cell therapy | “STIL101 for injection, an autologous (made from the patients own cells) cellular therapy” NCT06626256 ↗ |
| Route | Intravenous | “STIL101 for injection IV on day 0” NCT06626256 ↗ |